The Value of Collective SupportWelcome to the August 2025 edition of the One Nucleus eNews. The continuing cash-flow challenges in the life science sector in terms of raising investment, M&A deals, grant funding, or client recruitment by the service sector are making life tough at both the company and employee levels for many.
In such times, I find it reassuring to see how the ‘all in this together’ collective spirit comes to the fore and new strategies emerge to combat the downturn.
It definitely felt like a community coming together at the recent ON Helix conference, with…
Cambridge, UK – 4 August 2025: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that patient recruitment is complete in its Phase 1b First-in-Human trial, COMPOSER-1, of MB310 in ulcerative colitis (UC) patients.
This international trial has recruited 29 adult patients at clinical centres in the UK, Austria, Bulgaria, Poland and Spain. Initial results are expected by the end of 2025.
The COMPOSER-1 study is designed to investigate the safety, tolerability, and initial signals of…
UK-based creative leader joins global organisation for life science sales and marketing professionalsSAMPS — the US-based global professional network for sales and marketing professionals in science — has announced the appointment of David Lister, CEO of UK-based life science creative agency CLOK, to its Board of Directors.David’s appointment reflects SAMPS’s commitment to expanding its global reach and fostering innovation in how science is communicated and commercialised. Based in the UK, David brings over 20 years of experience helping life science companies clarify complex ideas and…
The July edition of our People Pathways newsletter is now available to read here!
Featuring:✅ One Nucleus upcoming courses✅ How Does One Nucleus Support Your People? - Article by Monalisa Breazu, Learning & Development Administrator✅ One Nucleus - Supporting a Biotech Industry in Lay-Off Mode - Find out more here.✅ We Want to Hear From You! - Thoughts on new training✅ Details on The Skills Summit by the Cambridgeshire Chambers of Commerce
July 28, 2025Devens, MA, USA — Veranova, a global leader in the development and manufacturing of specialty and complex active pharmaceutical ingredients (API) for the pharmaceutical and biotech sectors, is pleased to announce the appointment of Thomas Rohrer as Vice President of Bioconjugation. This appointment follows a recently announced investment to establish cGMP bioconjugation capabilities at its Devens, MA site.
Thomas brings over 40 years of experience and a comprehensive understanding of biological process development and clinical manufacturing, including 30 years of licensed…
Expert in targeted protein degradation and drug discovery will support development of the Company’s portfolio of novel small molecule degraders
Cambridge, UK, 28 July 2025: PhoreMost Ltd., a next-generation targeted protein degradation (TPD) company progressing a pipeline of degrader therapeutics within oncology and inflammation, today announced the appointment of Dr Adam Gilbert to its Scientific Advisory Board. In the role, Adam will support PhoreMost to advance its portfolio of novel small molecule degraders and molecular glues arising from its GlueSEEKER® platform.
Most recently an…
The UK government has officially launched its landmark Life Sciences Sector Plan, backed by over £2 billion in public funding and spearheaded by the Department for Science, Innovation and Technology, Business and Trade, and Health and Social Care.
The ambitious ten-year roadmap forms a central pillar of the government’s wider Industrial Strategy and its 10 Year Health Plan, aiming to position the UK as Europe’s leading and the world’s third largest life sciences economy by 2035.
The plan revolves around three core pillars:
1. Enabling World Class R&D – Enhancing the UK’s science…
Thursday 24th July, Cambridge, UK – Camgenium today announced its partnership with Professor Petre Cristian Ilie, Consultant Urological and Robotic Surgeon at NNUH NHS Foundation Trust, to develop HealthiumPro, a cloud-based innovative software solution. The system has the potential to improve the outcomes of prostate cancer patients by enhancing safety before and after surgery.
Prostate cancer is the most commonly diagnosed cancer in men in the UK, with 55,000 cases diagnosed annually. Its rate of incidence is expected to increase by 15% between 2023 and 2040.i,ii Many men with prostate…
Sandwich, UK (22 July 2025) – Discovery Park based Logical Biological – biospecimen and critical material experts – today announced the launch of a new sister company, Logical Antigen. The new company focuses on rapid and customised delivery of high-quality antigens and biologicals for research and manufacturing of diagnostic products.
Antigens are a key component in the manufacture of in vitro diagnostic (IVD) test reagents, often used in controls to confirm test performance. However, unmet needs currently exist in relation to protein derived material availability, suitability and consistent…
In the second quarter of 2025 Coulter Partners drove global executive search for a wide range of life sciences, health, and technology organizations. We successfully placed executives for venture capital & private equity-backed firms, alongside large-cap, mid-cap, and public companies, filling critical roles across diverse disciplines worldwide.CEO/ C-suite/ BoardCEO, ADC oncology company (VC-backed), UKCEO, Immuno-oncology therapeutics (Publicly listed), USCEO, Sustainable chemical biomanufacturing (VC-backed), SwedenCEO, Exosome technologies (VC-backed), ItalyChief Commercial…